-
Complex Epidemiology of Prostate Cancer in Asian Countries
- Kagenori Ito, Takahiro Kimura
-
J Urol Oncol. 2023;21(1):5-13.
-
Reivew Article
Mar 31, 2023
|
-
Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades
- Sang Heon Han, Hyeong Dong Yuk
-
J Urol Oncol. 2023;21(1):32-44.
-
Original Article
Mar 31, 2023
The Landscape of Epidemiology in Urologic Cancers
|
-
Prostate Imaging and Reporting and Data System Version 2.1: Limitations for Clinical Use
- Byung Kwan Park
-
J Urol Oncol. 2023;21(2):106-111.
-
Invited Review
Jul 31, 2023
mpMRI in the Management of Prostate Cancer: Role, Limitation, and Cost-Effectiveness
|
-
Understanding Cancer Pain and Controlling Pain: Focusing on Patients With Metastatic Urologic Cancer
- Jaemin Jo, Sanghoon Han, Jung-Sik Huh
-
Korean J Urol Oncol. 2021;19(1):23-29.
-
Review Article
Feb 26, 2021
|
-
The Effects of Recombinant Bacillus Calmette-Guérin Resistant to Antimicrobial Peptides on Orthotopic Bladder Cancer Mouse Model
- Seok Ju Hong, Gwang Yong Hwang, Su Jeong Kang, et al.
-
Korean J Urol Oncol. 2021;19(1):40-47.
-
Original Article
Feb 26, 2021
|
-
Utility of Next-Generation Sequencing for Deciphering Intratumor Heterogeneity in Prostate Cancer
- Je-Gun Joung, Joo-Young Park, So-Yun Yang, et al.
-
Korean J Urol Oncol. 2021;19(2):101-108.
-
Review Article
May 31, 2021
|
-
Predictive Factors of De Novo Overactive Bladder After Radical Prostatectomy in Patients With Clinically Localized Prostate Cancer: A Prospective Observational Study
- Jun Nyung Lee, Sang Won Kim, Kyeong-Hyeon Byeon, et al.
-
Korean J Urol Oncol. 2021;19(2):109-116.
-
Original Article
May 31, 2021
|
-
Predictive Factors for Acute Urinary Retention After Transperineal Template-Guided Mapping Biopsy
- Si Hyun Sung, Chung Un Lee, Jae Hoon Chung, et al.
-
Korean J Urol Oncol. 2021;19(3):148-154.
-
Original Article
Aug 31, 2021
|
-
Investigation of Information Acquisition Channel for Prostate Cancer High-Risk Group
- Yun-Sok Ha, Kwang Taek Kim, Wook Nam, et al.
-
Korean J Urol Oncol. 2021;19(3):174-182.
-
Original Article
Aug 31, 2021
|
-
Usefulness of Prostate-Specific Antigen Density as an Indicator for Recommending Prebiopsy Magnetic Resonance Imaging to Prevent Missed Prostate Cancer Diagnoses
- Jin Hyung Jeon, Kyo Chul Koo, Byung Ha Chung, et al.
-
Korean J Urol Oncol. 2021;19(3):155-163.
-
Original Article
Aug 31, 2021
|
-
Machine Learning Techniques in Prostate Cancer Diagnosis According to Prostate-Specific Antigen Levels and Prostate Cancer Gene 3 Score
- Roberto Passera, Stefano De Luca, Cristian Fiori, et al.
-
Korean J Urol Oncol. 2021;19(3):164-173.
-
Original Article
Aug 31, 2021
|
-
A Study on Metabolic Health Status as a Risk Factor for Female Bladder Cancer Incidence: Analysis From the National Health Checkups Database of Korea
- Da Eun Han, Sun Tae Ahn, Jong Wook Kim, et al.
-
Korean J Urol Oncol. 2021;19(4):223-231.
-
Original Article
Nov 25, 2021
|
-
The Important Role of Poly ADP-Ribose Polymerase Inhibitor in Prostate Cancer
- Jae Young Joung, Sung Han Kim
-
Korean J Urol Oncol. 2022;20(1):1-11.
-
Review Article
Feb 24, 2022
|
-
2021 Consensus Statements on the Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma From the Korean Renal Cancer Study Group (KRoCS)
- Chan Ho Lee, Minyong Kang, Cheol Kwak, et al.
-
Korean J Urol Oncol. 2022;20(3):151-162.
-
Review Article
Aug 25, 2022
|
-
An Update of Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer
- Jeong Hee Hong
-
Korean J Urol Oncol. 2022;20(4):207-222.
-
Review Article
Nov 30, 2022
|
-
A Survey on the Quality of Life of Prostate Cancer Patients in Korean Prostate Cancer Patients Association
- Yun-Sok Ha, Kwang Taek Kim, Wook Nam, et al.
-
Korean J Urol Oncol. 2022;20(4):265-272.
-
Original Article
Nov 30, 2022
|
-
Bladder Cancer in South Korea: Analysis of Trends and Risk Factors of Bladder Cancer in South Korea Using a Nationwide Database
- Sangjun Yoo, Kyung-Do Han, Kwang Taek Kim, et al.
-
J Urol Oncol. 2023;21(1):45-52.
-
Original Article
Mar 31, 2023
|
-
Bladder Preservation With Transurethral Tumor Resection and Intravesical BCG Instillation in Superficial Muscle-Invasive Bladder Cancer: A 10-Year Follow-up
- Dong Gyun Kim, Ji Eun Heo, Kang Su Cho, et al.
-
J Urol Oncol. 2023;21(1):70-78.
-
Original Article
Mar 31, 2023
|
-
A Cost-Benefit Comparison of Biparametric Magnetic Resonance Imaging Versus Conventional Prostate Cancer Screening
- Jung Sik Huh, Kyung Kgi Park
-
J Urol Oncol. 2023;21(2):121-127.
-
Original Article
Jul 31, 2023
mpMRI in the Management of Prostate Cancer: Role, Limitation, and Cost-Effectiveness
|
-
Korean Urologic Oncology Society Guidelines: Does Angioembolization Improve the Quality of Life for Renal Cell Carcinoma Patients With Intractable Symptoms Who Are Unfit for Surgery?
- Ja Yoon Ku, Hui Mo Gu, Seong Hyeon Yu, et al.
-
J Urol Oncol. 2023;21(2):140-147.
-
Invited Review
Jul 31, 2023
Genetic Testing and Nonsurgical Management for Renal Cell Carcinoma
|
-
The Role of Magnetic Resonance Imaging (MRI) and MRI-Targeted Biopsy for Active Surveillance
- Chang Wook Jeong
-
J Urol Oncol. 2023;21(2):97-105.
-
Invited Review
Jul 31, 2023
mpMRI in the Management of Prostate Cancer: Role, Limitation, and Cost-Effectiveness
|
-
The Evolving Role of Checkpoint Inhibitors in the Treatment of Urothelial Carcinoma: A Literature Review of Practice-Changing Trials
- Sang Hun Song, Jong Jin Oh
-
J Urol Oncol. 2023;21(2):154-164.
-
Invited Review
Jul 31, 2023
Trimodality Therapy and Immuno-Oncology for Bladder Cancer
|
-
Efficacy of Partial Nephrectomy in the Management of Unpredicted pT3a Renal Cell Carcinoma
- Dongsu Kim, Bumjin Lim, Jungyo Suh, et al.
-
J Urol Oncol. 2023;21(2):148-153.
-
Original Article
Jul 31, 2023
Genetic Testing and Nonsurgical Management for Renal Cell Carcinoma
|
-
The Predictive Value of the Preoperative Systemic Inflammatory Response Indices in Non–Organ-Confined Disease in Upper Urinary Tract Urothelial Carcinoma
- Sung Kyung Choi, Chan Hoon Gwak, Jungyo Suh, et al.
-
J Urol Oncol. 2023;21(2):174-180.
-
Original Article
Jul 31, 2023
Trimodality Therapy and Immuno-Oncology for Bladder Cancer
|
-
Impact of Multiparametric Magnetic Resonance Imaging for the Prediction of Extraprostatic Extension According to the National Comprehensive Cancer Network Risk Stratification in Prostate Cancer
- Jae Hoon Kang, Jun-Koo Kang, Jae-Wook Chung, et al.
-
J Urol Oncol. 2023;21(2):112-120.
-
Topic Article
Jul 31, 2023
mpMRI in the Management of Prostate Cancer: Role, Limitation, and Cost-Effectiveness
|
-
Radical Cystectomy Versus Bladder-Preserving Therapy in Muscle-Invasive Bladder Cancer Patients After Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multicenter Retrospective Analysis
- Youngheun Jo, Jun Seok Kim, Yoo Sub Shin, et al.
-
J Urol Oncol. 2023;21(2):165-173.
-
Original Article
Jul 31, 2023
Trimodality Therapy and Immuno-Oncology for Bladder Cancer
|
-
Genetic Testing for Prostate Cancer, Urothelial Cancer, and Kidney Cancer
- Hyunho Han, Minyong Kang, Seok-Soo Byun, et al.
-
J Urol Oncol. 2023;21(2):128-139.
-
Invited Review
Jul 31, 2023
Genetic Testing and Nonsurgical Management for Renal Cell Carcinoma
|
-
Influence of Body Composition on the Perioperative and Survival Outcomes of Renal Cell Carcinoma
- Edouard H. Nicaise, Benjamin N. Schmeusser, Yash B. Shah, et al.
-
J Urol Oncol. 2023;21(3):183-199.
-
Invited Review
Nov 30, 2023
Perioperative Considerations and Treatment for Advanced Renal Cell Carcinoma
|
-
Preoperative Renal Artery Embolization Before Radical Nephrectomy for Nonmetastatic Renal Cell Carcinoma: A Propensity Score Matched Analysis
- Jin Noh, Sang Hun Song, Gyoohwan Jung, et al.
-
J Urol Oncol. 2023;21(3):200-207.
-
Topic Article
Nov 30, 2023
Perioperative Considerations and Treatment for Advanced Renal Cell Carcinoma
|
-
The Future of Adjuvant Therapy in Renal Cell Carcinoma: Recent Insights and Prospects
- Hyerim Ha, Joo Han Lim
-
J Urol Oncol. 2023;21(3):208-216.
-
Invited Review
Nov 30, 2023
Perioperative Considerations and Treatment for Advanced Renal Cell Carcinoma
|